glp-1 stock price Breakingviews - Weight loss drugs face first economic stress test $350 → $245 → $149:

The conflicting data doesnt surprise Sheer

We have ORC in 5.62 cases per 1,000 persons in the BMS group and 5.89 cases per 1,000 persons in the GLP-1 group, said Wolff-Sagy

Patients who want to understand inflammation beyond weight loss can read the GLP-1 anti-inflammation benefits article

doi: 10.3389/fnmol.2021.793004 Received 11 October 2021 Accepted 29 November 2021 Published 17 December 2021 Volume 14 - 2021 Edited by Inmaculada Segura, Ludwig Maximilian University of Munich, Germany Reviewed by Jong-Woo Sohn, Korea Advanced Institute of Science and Technology, South Korea

Its discouraging. In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight up to 50 pounds or more in many cases